167 related articles for article (PubMed ID: 19798749)
1. Synergistic effect between proteasome and autophagosome in the clearance of polyubiquitinated TDP-43.
Urushitani M; Sato T; Bamba H; Hisa Y; Tooyama I
J Neurosci Res; 2010 Mar; 88(4):784-97. PubMed ID: 19798749
[TBL] [Abstract][Full Text] [Related]
2. Mutations in the ubiquitin-binding domain of OPTN/optineurin interfere with autophagy-mediated degradation of misfolded proteins by a dominant-negative mechanism.
Shen WC; Li HY; Chen GC; Chern Y; Tu PH
Autophagy; 2015 Apr; 11(4):685-700. PubMed ID: 25484089
[TBL] [Abstract][Full Text] [Related]
3. Degradation of TDP-43 and its pathogenic form by autophagy and the ubiquitin-proteasome system.
Wang X; Fan H; Ying Z; Li B; Wang H; Wang G
Neurosci Lett; 2010 Jan; 469(1):112-6. PubMed ID: 19944744
[TBL] [Abstract][Full Text] [Related]
4. Degradation of trafficking-defective long QT syndrome type II mutant channels by the ubiquitin-proteasome pathway.
Gong Q; Keeney DR; Molinari M; Zhou Z
J Biol Chem; 2005 May; 280(19):19419-25. PubMed ID: 15760896
[TBL] [Abstract][Full Text] [Related]
5. Znf179 E3 ligase-mediated TDP-43 polyubiquitination is involved in TDP-43- ubiquitinated inclusions (UBI) (+)-related neurodegenerative pathology.
Lee YC; Huang WC; Lin JH; Kao TJ; Lin HC; Lee KH; Lin HC; Shen CJ; Chang WC; Huang CC
J Biomed Sci; 2018 Nov; 25(1):76. PubMed ID: 30404641
[TBL] [Abstract][Full Text] [Related]
6. Potentiation of amyotrophic lateral sclerosis (ALS)-associated TDP-43 aggregation by the proteasome-targeting factor, ubiquilin 1.
Kim SH; Shi Y; Hanson KA; Williams LM; Sakasai R; Bowler MJ; Tibbetts RS
J Biol Chem; 2009 Mar; 284(12):8083-92. PubMed ID: 19112176
[TBL] [Abstract][Full Text] [Related]
7. Differential roles of the ubiquitin proteasome system and autophagy in the clearance of soluble and aggregated TDP-43 species.
Scotter EL; Vance C; Nishimura AL; Lee YB; Chen HJ; Urwin H; Sardone V; Mitchell JC; Rogelj B; Rubinsztein DC; Shaw CE
J Cell Sci; 2014 Mar; 127(Pt 6):1263-78. PubMed ID: 24424030
[TBL] [Abstract][Full Text] [Related]
8. PABPN1 suppresses TDP-43 toxicity in ALS disease models.
Chou CC; Alexeeva OM; Yamada S; Pribadi A; Zhang Y; Mo B; Williams KR; Zarnescu DC; Rossoll W
Hum Mol Genet; 2015 Sep; 24(18):5154-73. PubMed ID: 26130692
[TBL] [Abstract][Full Text] [Related]
9. Phosphorylated and ubiquitinated TDP-43 pathological inclusions in ALS and FTLD-U are recapitulated in SH-SY5Y cells.
Nonaka T; Arai T; Buratti E; Baralle FE; Akiyama H; Hasegawa M
FEBS Lett; 2009 Jan; 583(2):394-400. PubMed ID: 19111550
[TBL] [Abstract][Full Text] [Related]
10. Quantitative assessment of the degradation of aggregated TDP-43 mediated by the ubiquitin proteasome system and macroautophagy.
Cascella R; Fani G; Capitini C; Rusmini P; Poletti A; Cecchi C; Chiti F
FASEB J; 2017 Dec; 31(12):5609-5624. PubMed ID: 28842427
[TBL] [Abstract][Full Text] [Related]
11. Loss of TDP-43 Inhibits Amyotrophic Lateral Sclerosis-Linked Mutant SOD1 Aggresome Formation in an HDAC6-Dependent Manner.
Xia Q; Wang H; Zhang Y; Ying Z; Wang G
J Alzheimers Dis; 2015; 45(2):373-86. PubMed ID: 25720411
[TBL] [Abstract][Full Text] [Related]
12. Axonal ligation induces transient redistribution of TDP-43 in brainstem motor neurons.
Sato T; Takeuchi S; Saito A; Ding W; Bamba H; Matsuura H; Hisa Y; Tooyama I; Urushitani M
Neuroscience; 2009 Dec; 164(4):1565-78. PubMed ID: 19782731
[TBL] [Abstract][Full Text] [Related]
13. Cytoplasmic accumulation and aggregation of TDP-43 upon proteasome inhibition in cultured neurons.
van Eersel J; Ke YD; Gladbach A; Bi M; Götz J; Kril JJ; Ittner LM
PLoS One; 2011; 6(7):e22850. PubMed ID: 21829535
[TBL] [Abstract][Full Text] [Related]
14. Accelerated disease onset with stabilized familial amyotrophic lateral sclerosis (ALS)-linked mutant TDP-43 proteins.
Watanabe S; Kaneko K; Yamanaka K
J Biol Chem; 2013 Feb; 288(5):3641-54. PubMed ID: 23235148
[TBL] [Abstract][Full Text] [Related]
15. Cbl-mediated ubiquitination of alpha5 integrin subunit mediates fibronectin-dependent osteoblast detachment and apoptosis induced by FGFR2 activation.
Kaabeche K; Guenou H; Bouvard D; Didelot N; Listrat A; Marie PJ
J Cell Sci; 2005 Mar; 118(Pt 6):1223-32. PubMed ID: 15728256
[TBL] [Abstract][Full Text] [Related]
16. Upregulation of clusterin/apolipoprotein J in lactacystin-treated SH-SY5Y cells.
Carreras I; Garrett-Young R; Ullman MD; Eisenhauer PB; Fine RE; Wells JM; Conn KJ
J Neurosci Res; 2005 Feb; 79(4):495-502. PubMed ID: 15635600
[TBL] [Abstract][Full Text] [Related]
17. Identification and characterization of ubiquitinylation sites in TAR DNA-binding protein of 43 kDa (TDP-43).
Hans F; Eckert M; von Zweydorf F; Gloeckner CJ; Kahle PJ
J Biol Chem; 2018 Oct; 293(41):16083-16099. PubMed ID: 30120199
[TBL] [Abstract][Full Text] [Related]
18. Wild type and mutant amyloid precursor proteins influence downstream effects of proteasome and autophagy inhibition.
Cecarini V; Bonfili L; Cuccioloni M; Mozzicafreddo M; Rossi G; Keller JN; Angeletti M; Eleuteri AM
Biochim Biophys Acta; 2014 Feb; 1842(2):127-34. PubMed ID: 24215712
[TBL] [Abstract][Full Text] [Related]
19. Ubiquitin-Binding Protein CG5445 Suppresses Aggregation and Cytotoxicity of Amyotrophic Lateral Sclerosis-Linked TDP-43 in Drosophila.
Uechi H; Kuranaga E; Iriki T; Takano K; Hirayama S; Miura M; Hamazaki J; Murata S
Mol Cell Biol; 2018 Feb; 38(3):. PubMed ID: 29109084
[TBL] [Abstract][Full Text] [Related]
20. Cytoplasmic TDP-43 impairs the activity of the ubiquitin-proteasome system.
Yin P; Bai D; Zhu L; Deng F; Guo X; Li B; Chen L; Li S; Li XJ
Exp Neurol; 2021 Nov; 345():113833. PubMed ID: 34363810
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
